MARCHÉ Sevrage tabagique REMBOURSEMENT / REIMBURSEMENT patients, 39 % de part de fumeur gérer ses prises et, marché, qui enregistrent la notamment, ses manques plus forte hausse du sec- subits ou « craving ». Leur teur : + 44,7 % en décembre plus grande souplesse d’uti- CHAMPIX RENAÎT DE SES CENDRES 2017 en cumul annuel mobile lisation (arrêt temporaire ou CHAMPIX ARISES FROM ITS ASHES (OFDT). C’est, en effet, la définitif) explique leur poids galénique la plus prescrite plus important. Lancées en Le médicament Champix (Pfizer) fait la démonstration que le par les professionnels de 2013, les premières gommes remboursement, même partiel (65 %), d’un produit de sevrage santé. Un mode de sevrage génériques Eg (des géné- nicotinique, fait grimper les ventes (+ 113,6 %, source OFDT). passif qui dispense le riques de Nicorette 2 mg ou Pilonné par un déremboursement intervenu en 2011 en raison de fumeur de toute intervention 4 mg sans sucre) profitent possibles effets secondaires psychiatriques, son remboursement puisqu’il lui suffit de coller le au développement du seg- a été de nouveau autorisé en mai 2017 pour les prescriptions en patch à même la peau pour ment. « Vendues 30 % moins seconde intention après l’échec des stratégies comprenant des une diffusion en continu de cher que les autres gommes substituts nicotiniques chez les adultes ayant une forte dépendance la nicotine. Quant aux formes du marché, les gommes Eg au tabac. Sa molécule, la varénicline, se fixe sur les récepteurs orales (+ 17,6 %, source attirent les patients qui nicotiniques du cerveau et apaise les symptômes de manque. OFDT), qui représentent, en recherchent des produits équivalent patients, 55 % de économiques », explique Developed by Pfizer, Champix demonstrates that even the partial part de marché, elles pour- Florence Masson, directrice reimbursement (65%) of a smoking cessation product can suivent la même vocation marketing. Dernières nées, increase its sales (+113.6% according to OFDT). Stopped by its de sevrage en laissant le en 2016, les gommes Eg dereimbursement in 2011 due to the possible psychiatric side effects, its reimbursement was re-authorized in May 2017 for second-line prescriptions after the failure of strategies based on nicotine replacement therapy in adults highly addicted to tobacco. Its molecule, varenicline, binds to the nicotinic receptors in the brain and relieves the cessation symptoms. 32 strong visibility for its Patches register prescribed by health explains their significant references. It also provides the strongest growth professionals. A passive market share. Launched the pharmacists with patient smoking cessation method in 2013, the first generic support tools. Launched in Offered in several types of that spares the smoker gums Eg (generic version April, the box of 204 tablets, boxes, doses and flavours from making any efforts: all of Nicorette sugar-free 2 the only one of the kind on to meet the various needs one needs is to stick the mg or 4 mg) are taking the market, joins the other of patients, the different patch onto the skin and it advantage of the growth references that propose products in this sector do will continuously release in this sector. “Sold 30% 36, 96 and 144 tablets. “An not have similar growth nicotine. As for the oral cheaper than the other economic format which rates. It is transdermal forms (+17.6%, according chewing gums on this allows driving patients’ patches (packaged in to OFDT), which account market, the Eg chewing loyalty at a time when the sealed individual bags) for 55% market share (the gums are attracting those prices of products can be that account for 39% market equivalent number of patients that are looking considered as an obstacle to share - the equivalent patients), they serve the for economic products,” purchase,” Audrey Beladina number of patients - and same cessation purpose by Marketing Director says. Taken over by show the highest growth allowing the smokers to Florence Masson explains. Omega Pharma, the brand in this sector: +44.7% in manage the intakes and, The latest addition to the Niquitin stands out through December 2017 in moving in particular, the sudden range was made in 2016, its transparent patches, annual total value (OFDT). cravings. Their higher the Eg chewing gums with designed to ensure greater This actually is the dosage flexibility of use (temporary a fruit flavour, without discretion. form the most frequently or definitive cessation) sugar and aspartame. The Avril / Mai / Juin - 2018Doses 71 /Le Magazine du Packaging des Produits de Santé